Abstract：Objective To analyze the relationship between the dose volume of bone marrow and acute hematologic toxicity in craniospinal irradiation (CSI),and preliminarily explore the dosimetric differences in bone marrow between helical tomotherapy (HT) and volumetric modulated arc therapy (VMAT). Methods Clinical data and HT plans of twenty patients treated with CSI in the First Affiliated Hospital of Kunming Medical University were collected, and the HT plans were transferred back to the MIM system. The skull, mandible, clavicle, sternum, scapula, ribs, vertebrae and pelvis were successively delineated on the CT images and then the V2,V5,V10,V15,V20,V25,V30,V35,Dmax,Dmean of each aforementioned bone and total bone were read on DVH images. The correlation between those indexes and the incidence of ≥grade Ⅱ hematologic toxicity was subsequently analyzed. The images of 6 patients were selected and transferred to Monaco TPS and VMAT plans were completed. The dosimetric differences of those indexes were statistically compared between HT and VMAT. Statistical analyses were performed by using Spearman correlation analysis and Wilcoxon symbol rank-sum test. Results The incidence of ≥grade Ⅱ leukopenia was positively correlated with the V25 of pelvis and the V5 of total bones (P=0.038);the risk of ≥ grade Ⅱ thrombocytopenia was positive associated with the V20 of pelvis (P=0.041);the incidence of ≥ grade Ⅱ neutropenia was positively correlated with the V10 of vertebrae (P=0.036). There was no dosimetric difference of dose volume of vertebral and pelvis between HT and VMAT plans (P>0.05). Conclusions There is a positive correlation between ≥ grade Ⅱ leukopenia and the V25 of pelvis and the V5 of total bones. The V20 of pelvis shows a positive correlation with ≥ grade Ⅱ thrombocytopenia. A positive correlation is found between ≥ grade Ⅱ neutropenia and the V10 of vertebrae. The indices of vertebral and pelvis between HT and VMAT plans show no significant differences.
Chen Shan,Li Rongqing. A preliminary study of the protection of bone marrow in craniospinal irradiation[J]. Chinese Journal of Radiation Oncology, 2018, 27(5): 445-448.
[1]Parker K,Gallop-Evans E,Hanna L,et al. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy:results from a single institution[J].Int J Radiat Oncol Biol Phys,2009,74(1):140-146.DOI:10.1016/j.ijrobp.2008.06.1920. [2]Adamus R,Loose R,Wucherer M,et al. Strahlenschutz in der interventionellen Radiologie[J].Radiologe,2016,56(3):275-281.DOI:10.1007/s00117-016-0083-0. [3]Brink JA,Miller DL.NCRP program area committee 4:radiation protection in medicine[J].Health Phys,2016,110(2):106-108.DOI:10.1097/HP.0000000000000403. [4]Sacchetti B,Funari A,Michienzi S,et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment[J].Cell,2007,131(2):324-336.DOI:10.1016/j.cell.2007.08.025. [5]Mettler FA.Medical effects and risks of exposure to ionising radiation[J].J Radiol Prot,2012,32(1):N9-N13.DOI:10.1088/0952-4746/32/1/N9. [6]Ellis RE.The distribution of active bone marrow in the adult[J].Phys Med Biol,1961,5:255-258.DOI:10.1088/0031-9155/5/3/302. [7]Studenski MT,Shen XL,Yu Y,et al. Intensity-modulated radiation therapy and volumetric-modulated arc therapy for adult craniospinal irradiation—A comparison with traditional techniques[J].Med Dosim,2013,38(1):48-54.DOI:10.1016/j.meddos.2012.05.006. [8]Fogliata A,Bergström S,Cafaro I,et al. Cranio-spinal irradiation with volumetric modulated arc therapy:a multi-institutional treatment experience[J].Radiother Oncol,2011,99(1):79-85.DOI:10.1016/j.radonc.2011.01.023. [9]Chen JZ,Chen CZ,Atwood TF,et al. Volumetric modulated arc therapy planning method for supine craniospinal irradiation[J].J Radiat Oncol,2012,1(3):291-297.DOI:10.1007/s13566-012-0028-9. [10]Parker W,Brodeur M,Roberge D,et al. Standard and nonstandard craniospinal radiotherapy using helical tomotherapy[J].Int J Radiat Oncol Biol Phys,2010,77(3):926-931.DOI:10.1016/j.ijrobp.2009.09.020. [11]Sharma DS,Gupta T,Jalali R,et al. High-precision radiotherapy for craniospinal irradiation:evaluation of three-dimensional conformal radiotherapy,intensity-modulated radiation therapy and helical tomotherapy[J].Br J Radiol,2009,82(984):1000-1009.DOI:10.1259/bjr/13776022. [12]Riet FG,Bolle S,Brard C,et al. Craniospinal irradiation in children with high risk medulloblastoma haematological toxicity and risk factors[J].Neuro Oncol,2016,18(3):iii161.DOI:10.1093/neuonc/now082.12. [13]Petersson K,Gebre-Medhin M,Ceberg C,et al. Haematological toxicity in adult patients receiving craniospinal irradiation-Indication of a dose-bath effect[J].Radiother Oncol,2014,111(1):47-51.DOI:10.1016/j.radonc.2014.01.020. [14]Barney CL,Brown AP,Grosshans DR,et al. Technique,outcomes,and acute toxicities in adults treated with proton beam craniospinal irradiation[J].Neuro Oncol,2014,16(2):303-309.DOI:10.1093/neuonc/not155. [15]McGuire SM,Menda Y,Ponto LLB,et al. A methodology for incorporating functional bone marrow sparing in IMRT planning for pelvic radiation therapy[J].Radiother Oncol,2011,99(1):49-54.DOI:10.1016/j.radonc.2011.01.025. [16]McGuire SM,Menda Y,Ponto LLB,et al. Spatial mapping of functional pelvic bone marrow using FLT PET[J].J Appl Clin Med Phys,2014,15(4):129-136.DOI:10.1120/jacmp.v15i4.4780.
2018, Vol. 27 
